NEUROSENTIA™ is a first-of-its-kind, multi-pathway nutraceutical formulated to target moderate to severe Alzheimer’s and cognitive decline. It combines clinically studied ingredients that address brain insulin resistance, neuroinflammation, and mitochondrial dysfunction — core drivers of neurodegeneration. Designed with gender-specific components and validated nutrient stacks, NEUROSENTIA™ is positioned to disrupt the $6.5B global cognitive support market.
Skip to main content
